Cargando…

HTLV-1 Tax-Mediated Inhibition of FOXO3a Activity Is Critical for the Persistence of Terminally Differentiated CD4(+) T Cells

The mechanisms involved in the persistence of activated CD4(+) T lymphocytes following primary human T leukemia/lymphoma virus type 1 (HTLV-1) infection remain unclear. Here, we demonstrate that the HTLV-1 Tax oncoprotein modulates phosphorylation and transcriptional activity of the FOXO3a transcrip...

Descripción completa

Detalles Bibliográficos
Autores principales: Olagnier, David, Sze, Alexandre, Bel Hadj, Samar, Chiang, Cindy, Steel, Courtney, Han, Xiaoying, Routy, Jean-Pierre, Lin, Rongtuan, Hiscott, John, van Grevenynghe, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270795/
https://www.ncbi.nlm.nih.gov/pubmed/25521510
http://dx.doi.org/10.1371/journal.ppat.1004575
Descripción
Sumario:The mechanisms involved in the persistence of activated CD4(+) T lymphocytes following primary human T leukemia/lymphoma virus type 1 (HTLV-1) infection remain unclear. Here, we demonstrate that the HTLV-1 Tax oncoprotein modulates phosphorylation and transcriptional activity of the FOXO3a transcription factor, via upstream activation of the AKT pathway. De novo HTLV-1 infection of CD4(+) T cells or direct lentiviral-mediated introduction of Tax led to AKT activation and AKT-dependent inactivation of FOXO3a, via phosphorylation of residues Ser253 and Thr32. Inhibition of FOXO3a signalling led to the long-term survival of a population of highly activated, terminally differentiated CD4(+)Tax(+)CD27(neg)CCR7(neg) T cells that maintained the capacity to disseminate infectious HTLV-1. CD4(+) T cell persistence was reversed by chemical inhibition of AKT activity, lentiviral-mediated expression of a dominant-negative form of FOXO3a or by specific small interfering RNA (siRNA)-mediated silencing of FOXO3a. Overall this study provides new mechanistic insight into the strategies used by HTLV-1 to increase long-term maintenance of Tax(+)CD4(+) T lymphocytes during the early stages of HTLV-1 pathogenesis.